Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Assets Average (2021 - 2024)

Immuneering has reported Assets Average over the past 4 years, most recently at $72.8 million for Q3 2024.

  • Quarterly results put Assets Average at $72.8 million for Q3 2024, down 39.0% from a year ago — trailing twelve months through Sep 2024 was $72.8 million (down 39.0% YoY), and the annual figure for FY2023 was $112.5 million, down 22.18%.
  • Assets Average for Q3 2024 was $72.8 million at Immuneering, down from $82.5 million in the prior quarter.
  • Over the last five years, Assets Average for IMRX hit a ceiling of $165.4 million in Q4 2021 and a floor of $72.8 million in Q3 2024.
  • Median Assets Average over the past 4 years was $116.3 million (2023), compared with a mean of $119.7 million.
  • Biggest five-year swings in Assets Average: grew 27.02% in 2022 and later plummeted 39.0% in 2024.
  • Immuneering's Assets Average stood at $165.4 million in 2021, then fell by 22.58% to $128.0 million in 2022, then decreased by 15.46% to $108.2 million in 2023, then tumbled by 32.72% to $72.8 million in 2024.
  • The last three reported values for Assets Average were $72.8 million (Q3 2024), $82.5 million (Q2 2024), and $95.3 million (Q1 2024) per Business Quant data.